PURPOSE The call to integrate prospective surveillance for lymphedema into cancer care
pathways is building momentum to enable early intervention and prevent the progression of …

Objectives To provide an overview of costs associated with the treatment of breast cancer-
related lymphoedema (BCRL) and its possible sequelae, borne by patients or by society …

Questions When added to decongestive lymphatic therapy (DLT), what is the effect of
fluoroscopy-guided manual lymphatic drainage (MLD) versus traditional MLD or placebo …

Background Risk assessment for breast cancer–related lymphedema has emphasized
upper‐limb symptoms and treatment‐related risk factors. This article examined breast …

Purpose To identify physical activity level, exercise behavior, barriers, and preferences in
female patients with breast cancer–related lymphedema (BCRL). Methods Patients with …

Significance: Lymphedema is a common, distressing and debilitating condition with various
etiologies. Effective diagnosis, assessment, and management rely on evidence-based …

Background Lymphoedema is a common, distressing, and debilitating condition affecting
more than 200 million people globally. There is a small body of evidence to guide …

Introduction Breast edema can arise from different etiologies; however, it is mostly seen after
breast conserving surgery and/or radiotherapy. Combining breast conserving surgery and …

Lymphedema is an important medical issue around the world, caused by an anomalous
collection of fluid in soft tissue due to congenital malformations or stenosis or obstruction of …

Background: Patients with breast cancer-related lymphedema (BCRL) have lower quality of
life (QOL). However, some important predictors, such as the effect of age, lymphedema …